Corpus ID: 29939902

An overview of the drug approval process.

@article{Martinez2002AnOO,
  title={An overview of the drug approval process.},
  author={L Joel Martinez},
  journal={Research initiative, treatment action : RITA},
  year={2002},
  volume={8 1},
  pages={
          11-7
        }
}
  • L. J. Martinez
  • Published 2002
  • Medicine
  • Research initiative, treatment action : RITA

Topics from this paper

Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention
TLDR
This work discusses selected challenges for conducting pharmacovigilance and epidemiologic studies of AEs after vaccination in the United States using the post-licensure safety surveillance infrastructure of the Centers for Disease Control and Prevention (CDC). Expand
Fast protein sequencing of monoclonal antibody by real-time digestion on emitter during nanoelectrospray
TLDR
A fast method for sequencing recombinant monoclonal antibodies using a novel digestion-on-emitter technology, which offers a major advantage over N-terminal Edman sequencing and traditional peptide mapping methods in the identification of protein sequence, and is capable of meeting an ever-increasing demand for monoconal antibody sequence confirmation in the biopharmaceutical industry. Expand
A SYSTEMS APPROACH TO UNDERSTANDING THE HISTORY OF U.S. PEDIATRIC BIOLOGIC DRUG RESEARH AND LABELING
TLDR
A hybrid version of Hughes’s systems approach is proposed and used to explain the changes that occurred in the drug approval system in response to the push for, opposition, and inclusion of, pediatric research in drug development during the period 1950-2003. Expand
Irreversible treatment decisions under consideration of the research and development pipeline for new therapies
This article addresses a topic not considered in previous models of patient treatment: the possible downstream availability of improved treatment options coming out of the medical research andExpand